RENE SIO: Open Payments
NPI 1710726203 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,563 in 100 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $122 · 2025 $2,563
Food & beverage: $2,464Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 14 | $349 |
| Neurocrine BioSciences, Inc. | 11 | $345 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $305 |
| Teva Pharmaceuticals USA, Inc. | 9 | $251 |
| Axsome Therapeutics, Inc. | 6 | $170 |
| Alkermes, Inc. | 8 | $165 |
| Otsuka America Pharmaceutical, Inc. | 6 | $162 |
| E.R. Squibb & Sons, L.L.C. | 3 | $159 |
| Corium, LLC | 8 | $138 |
| Vanda Pharmaceuticals Inc. | 5 | $131 |
Products named: INGREZZA, CAPLYTA, SPRAVATO, Auvelity, COBENFY, Azstarys, LYBALVI, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
